Clinical Trial Update: Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer [NA]

View source ↗

Summary

A completed pediatric trial evaluated molecular-guided therapy for relapsed and refractory cancers, including neuroblastoma and medulloblastoma, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma
• Neuroblastoma

Snippet

Sponsor: Giselle Sholler | Conditions: Neuroblastoma, Medulloblastoma | NA | Status: COMPLETED | Results posted: 2024-04-26